Latest Partnerships News

Challenger Gold Limited has formalized an Investment Protection Agreement with Ecuador, safeguarding its $75 million investment in the El Guayabo Project. Concurrently, the company announced a doubling of its Mineral Resource Estimate to 9.1 million ounces gold equivalent across its Ecuadorian assets.

Generation Development Group (GDG) has forged a strategic alliance with BlackRock, combining local market leadership with global investment expertise to develop innovative retirement income solutions for Australian retirees.

Sparc Technologies is progressing its innovative green hydrogen pilot plant and graphene-based anti-corrosion trials, supported by a recent A$2.7 million capital raise to accelerate commercialisation and R&D.

NTAW Holdings has terminated its Australian Dunlop tyre distribution agreements, entering new contracts with Sumitomo Rubber Industries and Goodyear entities, while continuing Dunlop distribution in New Zealand. The move marks a strategic pivot as NTAW aims to grow other business units and reduce costs.

Centaurus Metals’ Jaguar Nickel Sulphide Project in Brazil has further reduced its carbon emissions, reinforcing its status as a world-leading low-emission nickel producer and attracting strategic investor interest.

Algorae Pharmaceuticals has partnered with Peter MacCallum Cancer Centre to validate AI-predicted drug combinations across multiple cancer types, aiming to accelerate its oncology pipeline development.

Aurora Labs has reached a critical design freeze milestone under its Australian Defence Force contract, advancing its novel 3D-printed propulsion system towards testing and validation phases.

ARN Media reports resilient 2024 financials driven by digital growth and Cody Outdoor contracts, launching a major cost-cutting transformation to sharpen its competitive edge.

Carnegie Clean Energy has partnered with global industrial leader SKF to co-develop and manufacture the Power Take-Off system for its CETO wave energy technology, marking a key step in commercialising ocean energy in Europe.

Transurban Group is streamlining operations with a workforce reduction of around 300 roles, targeting over $50 million in annual cost savings while maintaining its FY25 distribution guidance.

LTR Pharma has partnered with Strategic Drug Solutions to co-develop OROFLOW®, a novel intranasal spray aimed at providing fast symptom relief for Oesophageal Motility Disorders, tapping into a growing $4.5 billion global market.

Growthpoint Properties Australia has raised its FY25 funds from operations guidance and expanded its logistics portfolio with a $40 million industrial asset acquisition in Queensland, signaling strong operational momentum.